Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05513846 · ClinicalTrials.gov registry record
Brain Age and Sleep Architecture in Meditators
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 108
- Enrollment target
NCT05513846: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT05513846 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05513846 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
This is a single-center, cross-sectional study that will recruit approximately fifty seven (57) meditators and fifty one (51) controls. Individuals that have learned at least the Shambhavi Mahamudra Kriya practice and live in Massachusetts will be mailed a DREEM EEG device, and a sleepimage ring. Participants will be asked to wear the two devices while sleeping for three consecutive weekday nights (Sunday night to Thursday night) and two weekend nights (Friday and Saturday nights). While meditating during the day, participants will only wear the DREEM EEG headband. Participants will also undergo neurocognitive tests from the NIH toolbox during one virtual visit via video call. Meditators who join the study will be asked to invite a control subject to the study, matched for age and comorbidities.
Primary Outcome
Brain Age will be calculated using an algorithm from the sleeping EEG. A Brain Age index score will be created for each participant based on an aggregate of the five days of sleeping EEG data. The Brain Age Index is the brain age calculated from the algorithm subtracted by the chronological age of the participant.
Interventions
- DEVICE SleepImage Ring
- DEVICE DREEM EEG Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2025-12-31 |
What the finished NCT05513846 record still lists
NCT05513846 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which SleepImage Ring is the first listed.
NCT05513846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05513846 about?
NCT05513846 is a clinical study titled "Brain Age and Sleep Architecture in Meditators". This is a single-center, cross-sectional study that will recruit approximately fifty seven (57) meditators and fifty one (51) controls. Individuals that have learned at least the Shambhavi Mahamudra Kriya practice and live in Massachusetts will be mailed a DREEM EEG device, and a sleepimage ring. Pa...
What is the current status of trial NCT05513846?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2022-11-10. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05513846?
The interventions under investigation include: SleepImage Ring (DEVICE), DREEM EEG Device (DEVICE).
Who is sponsoring clinical trial NCT05513846?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI